Literature DB >> 6897019

Pulmonary uptake of liposomal phosphatidylcholine upon intratracheal administration to rats.

Y Morimoto, Y Adachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6897019     DOI： 10.1248/cpb.30.2248

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  8 in total

1.  Liposomes for controlled delivery of drugs to the lung.

Authors:  K M Taylor; J M Newton
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

3.  Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.

Authors:  Elke Kleemann; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Thomas Kissel; Werner Seeger
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

4.  Pulmonary delivery of free and liposomal insulin.

Authors:  F Y Liu; Z Shao; D O Kildsig; A K Mitra
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 5.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

6.  The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

Authors:  K M Taylor; G Taylor; I W Kellaway; J Stevens
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

7.  Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells.

Authors:  J R Wright; J D Borchelt; S Hawgood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 8.  Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.

Authors:  Mindaugas Rudokas; Mohammad Najlah; Mohamed Albed Alhnan; Abdelbary Elhissi
Journal:  Med Princ Pract       Date:  2016-03-02       Impact factor: 1.927
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.